What is being bought
This is an independent evaluation of the Widening Access Demonstrators (WAD) programme, to ensure an objective and impartial assessment of effectiveness, impact and value for money. The evaluation is a Ministerial requirement, a condition of support for the programme and will aim to bring together best practice case studies and to identify cross-cutting barriers and facilitators to delivery to codify best practice for a potential future national roll-out in 2027-28.
RF Healthcare is not the contracting authority. Check the original source for eligibility, lots, deadlines and instructions. Inclusion does not guarantee that a supplier can participate.
View published source